These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

840 related items for PubMed ID: 10094049

  • 1. The kinase TAK1 can activate the NIK-I kappaB as well as the MAP kinase cascade in the IL-1 signalling pathway.
    Ninomiya-Tsuji J, Kishimoto K, Hiyama A, Inoue J, Cao Z, Matsumoto K.
    Nature; 1999 Mar 18; 398(6724):252-6. PubMed ID: 10094049
    [Abstract] [Full Text] [Related]

  • 2. Tanshinone IIA inhibits LPS-induced NF-kappaB activation in RAW 264.7 cells: possible involvement of the NIK-IKK, ERK1/2, p38 and JNK pathways.
    Jang SI, Kim HJ, Kim YJ, Jeong SI, You YO.
    Eur J Pharmacol; 2006 Aug 07; 542(1-3):1-7. PubMed ID: 16797002
    [Abstract] [Full Text] [Related]

  • 3. MAP3K-related kinase involved in NF-kappaB induction by TNF, CD95 and IL-1.
    Malinin NL, Boldin MP, Kovalenko AV, Wallach D.
    Nature; 1997 Feb 06; 385(6616):540-4. PubMed ID: 9020361
    [Abstract] [Full Text] [Related]

  • 4. TAB2, TRAF6 and TAK1 are involved in NF-kappaB activation induced by the TNF-receptor, Edar and its adaptator Edaradd.
    Morlon A, Munnich A, Smahi A.
    Hum Mol Genet; 2005 Dec 01; 14(23):3751-7. PubMed ID: 16251197
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Induction of nuclear factor-kappaB activation through TAK1 and NIK by diesel exhaust particles in L2 cell lines.
    Yun YP, Joo JD, Lee JY, Nam HY, Kim YH, Lee KH, Lim CS, Kim HJ, Lim YG, Lim Y.
    Toxicol Lett; 2005 Feb 15; 155(2):337-42. PubMed ID: 15603929
    [Abstract] [Full Text] [Related]

  • 7. Evidence that TNF-TNFR1-TRADD-TRAF2-RIP-TAK1-IKK pathway mediates constitutive NF-kappaB activation and proliferation in human head and neck squamous cell carcinoma.
    Jackson-Bernitsas DG, Ichikawa H, Takada Y, Myers JN, Lin XL, Darnay BG, Chaturvedi MM, Aggarwal BB.
    Oncogene; 2007 Mar 01; 26(10):1385-97. PubMed ID: 16953224
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Toll-like receptor 4 signalling is specifically TGF-beta-activated kinase 1 independent in synovial fibroblasts.
    Geurts J, van den Brand BT, Wolf A, Abdollahi-Roodsaz S, Arntz OJ, Kracht M, van den Berg WB, van de Loo FA.
    Rheumatology (Oxford); 2011 Jul 01; 50(7):1216-25. PubMed ID: 21335610
    [Abstract] [Full Text] [Related]

  • 12. TNF/IL-1/NIK/NF-kappa B transduction pathway: a comparative study in normal and pathological human prostate (benign hyperplasia and carcinoma).
    Nuñez C, Cansino JR, Bethencourt F, Pérez-Utrilla M, Fraile B, Martínez-Onsurbe P, Olmedilla G, Paniagua R, Royuela M.
    Histopathology; 2008 Aug 01; 53(2):166-76. PubMed ID: 18752500
    [Abstract] [Full Text] [Related]

  • 13. Thioredoxin inhibits tumor necrosis factor- or interleukin-1-induced NF-kappaB activation at a level upstream of NF-kappaB-inducing kinase.
    Takeuchi J, Hirota K, Itoh T, Shinkura R, Kitada K, Yodoi J, Namba T, Fukuda K.
    Antioxid Redox Signal; 2000 Aug 01; 2(1):83-92. PubMed ID: 11232604
    [Abstract] [Full Text] [Related]

  • 14. Functional interactions of transforming growth factor beta-activated kinase 1 with IkappaB kinases to stimulate NF-kappaB activation.
    Sakurai H, Miyoshi H, Toriumi W, Sugita T.
    J Biol Chem; 1999 Apr 09; 274(15):10641-8. PubMed ID: 10187861
    [Abstract] [Full Text] [Related]

  • 15. Molecular mediators of alphavbeta3-induced endothelial cell survival.
    Rice J, Courter DL, Giachelli CM, Scatena M.
    J Vasc Res; 2006 Apr 09; 43(5):422-36. PubMed ID: 16888388
    [Abstract] [Full Text] [Related]

  • 16. TAK1 is a ubiquitin-dependent kinase of MKK and IKK.
    Wang C, Deng L, Hong M, Akkaraju GR, Inoue J, Chen ZJ.
    Nature; 2001 Jul 19; 412(6844):346-51. PubMed ID: 11460167
    [Abstract] [Full Text] [Related]

  • 17. ASK1 inhibits interleukin-1-induced NF-kappa B activity through disruption of TRAF6-TAK1 interaction.
    Mochida Y, Takeda K, Saitoh M, Nishitoh H, Amagasa T, Ninomiya-Tsuji J, Matsumoto K, Ichijo H.
    J Biol Chem; 2000 Oct 20; 275(42):32747-52. PubMed ID: 10921914
    [Abstract] [Full Text] [Related]

  • 18. NIK is a component of the EGF/heregulin receptor signaling complexes.
    Chen D, Xu LG, Chen L, Li L, Zhai Z, Shu HB.
    Oncogene; 2003 Jul 10; 22(28):4348-55. PubMed ID: 12853971
    [Abstract] [Full Text] [Related]

  • 19. Epstein-Barr virus-encoded latent membrane protein 1 activates the JNK pathway through its extreme C terminus via a mechanism involving TRADD and TRAF2.
    Eliopoulos AG, Blake SM, Floettmann JE, Rowe M, Young LS.
    J Virol; 1999 Feb 10; 73(2):1023-35. PubMed ID: 9882303
    [Abstract] [Full Text] [Related]

  • 20. NF-kappaB activation by a signaling complex containing TRAF2, TANK and TBK1, a novel IKK-related kinase.
    Pomerantz JL, Baltimore D.
    EMBO J; 1999 Dec 01; 18(23):6694-704. PubMed ID: 10581243
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.